IHAM

Integral Health Asset Management Portfolio holdings

AUM $1.37B
1-Year Est. Return 69.45%
This Quarter Est. Return
1 Year Est. Return
+69.45%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.07B
AUM Growth
+$168M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
98
New
Increased
Reduced
Closed

Top Buys

1
+$26.9M
2
+$26.3M
3
+$23.5M
4
LLY icon
Eli Lilly
LLY
+$19.5M
5
CRL icon
Charles River Laboratories
CRL
+$17.4M

Top Sells

1
+$19.6M
2
+$15.6M
3
+$12.8M
4
KRYS icon
Krystal Biotech
KRYS
+$10.8M
5
BSX icon
Boston Scientific
BSX
+$10.7M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXAS icon
51
Exact Sciences
EXAS
$19.4B
$5.31M 0.49%
+100,000
WAT icon
52
Waters Corp
WAT
$23.4B
$5.24M 0.48%
15,000
-5,000
GKOS icon
53
Glaukos
GKOS
$6.89B
$5.16M 0.47%
+50,000
ELAN icon
54
Elanco Animal Health
ELAN
$12.1B
$5M 0.46%
+350,000
COO icon
55
Cooper Companies
COO
$15.9B
$4.98M 0.46%
+70,000
CRSP icon
56
CRISPR Therapeutics
CRSP
$5.29B
$4.86M 0.45%
100,000
-50,000
TARA icon
57
Protara Therapeutics
TARA
$332M
$4.24M 0.39%
1,400,000
BHVN icon
58
Biohaven
BHVN
$1.79B
$4.23M 0.39%
300,000
+125,000
SANA icon
59
Sana Biotechnology
SANA
$1.29B
$4.09M 0.37%
1,500,000
-500,000
RARE icon
60
Ultragenyx Pharmaceutical
RARE
$2.34B
$3.64M 0.33%
+100,000
SRRK icon
61
Scholar Rock
SRRK
$4.52B
$3.54M 0.32%
100,000
-25,000
NRIX icon
62
Nurix Therapeutics
NRIX
$1.88B
$3.53M 0.32%
310,000
+35,000
JSPR icon
63
Jasper Therapeutics
JSPR
$43.9M
$3.27M 0.3%
590,000
+15,000
CPRX icon
64
Catalyst Pharmaceutical
CPRX
$2.9B
$3.25M 0.3%
150,000
ALKS icon
65
Alkermes
ALKS
$5.55B
$2.86M 0.26%
100,000
-50,000
TERN icon
66
Terns Pharmaceuticals
TERN
$3.73B
$2.61M 0.24%
700,000
RCUS icon
67
Arcus Biosciences
RCUS
$2.74B
$2.44M 0.22%
+300,000
OSCR icon
68
Oscar Health
OSCR
$4.52B
$2.14M 0.2%
100,000
-100,000
TENX icon
69
Tenax Therapeutics
TENX
$91.8M
$962K 0.09%
167,000
ANRO icon
70
Alto Neuroscience
ANRO
$516M
$880K 0.08%
400,000
BDX icon
71
Becton Dickinson
BDX
$57.5B
– –
-20,000
BMY icon
72
Bristol-Myers Squibb
BMY
$111B
– –
-100,000
BNTX icon
73
BioNTech
BNTX
$29.1B
– –
-40,000
BPMC
74
DELISTED
Blueprint Medicines
BPMC
– –
-145,000
ACLX icon
75
Arcellx
ACLX
$3.91B
– –
0
1 2
3
4